Deep learning-based radiomics model from pretreatment ADC to predict biochemical recurrence in advanced prostate cancer.
Journal Information
Journal Title: Front Oncol
Detailed journal information not available.
Publication Details
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Conflict of interest Author YZ was employed by the company Beijing Smart Tree Medical Technology Co. Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."
Funding Disclosure
Evidence found in paper:
"The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was funded by National High Level Hospital Clinical Research Funding (Scientific Research Seed Fund of Peking University First Hospital) (2022SF52)."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025